# SafeTraces

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/safetraces

- Industry: Biotechnology
- Headquarters: Pleasanton, US
- Website: www.safetraces.com
- Total disclosed funding: $21M
- Latest round: Series A (Sep 21, 2018)
- Investors on record: 8

## About

SafeTraces, Inc. specializes in biotech-based data analytics, providing solutions to predict, detect, and prevent pathogen exposure across various industries, particularly in healthcare and education.Founded in 2015 and headquartered in Pleasanton, US, SafeTraces, Inc. operates a biotechnology platform focused on pathogen detection. The company has undergone significant developments since its inception, securing a total of 3 deals. Erik Malmstrom leads the company as CEO. In September 2018, SafeTraces raised USD 10.00 mn in a Series A funding round co-led by Bunge Limited with participation from S2G Ventures, Spero Ventures, and UL Ventures.SafeTraces offers a biotech-powered data analytics platform designed to predict, detect, and prevent pathogen exposures in various environments. The core product, PathogenSentinel™, is an automated qPCR-biosensor platform that enables rapid detection and mitigation of pathogens, catering to industries such as healthcare, education, and corporate real estate. The platform leverages real-time analytics to enhance indoor environmental safety, addressing critical use cases like reducing hospital-acquired infections and ensuring compliance with health standards. SafeTraces serves a diverse client base, including K-12 schools, higher education institutions, healthcare facilities, and critical infrastructure sectors, primarily focused on the United States.SafeTraces generates revenue through a subscription-based model for its PathogenSentinel™ platform, facilitating B2B transactions across various sectors. Clients typically engage in multi-year contracts for platform deployment, ensuring ongoing support and updates. Pricing structures vary based on implementation scale and client needs. The company may also partner with organizations in the biodefense and healthcare sectors to provide integrated solutions that enhance indoor safety measures, thereby fostering long-term relationships for consistent revenue streams.SafeTraces aims to continue its growth by developing new products and expanding into new markets. The company plans to leverage the recent USD 10.00 mn raised in its Series A funding round in September 2018 to support these initiatives. Specific markets for future expansion are being explored, with a focus on enhancing its presence in both domestic and international sectors. Further product launches are anticipated, although specific details on new offerings and timelines have not been disclosed.

## Funding rounds

- Series A, Sep 21, 2018, $10M — Bunge Limited, S2G Ventures, UL Ventures, Spero Ventures
- Series A, Sep 7, 2017, $9M — Tuscan Ventures, City Light Capital, Omidyar Network, S2G Ventures, Maumee Ventures, UL Ventures
- Seed, Aug 25, 2016, $1.5M — Maumee Ventures

## Investors

- Maumee Ventures (https://capitalatlas.ai/funds/maumee-ventures) — Seed, Series A
- Tuscan Ventures (https://capitalatlas.ai/funds/tuscan-ventures) — Series A
- City Light Capital (https://capitalatlas.ai/funds/city-light-capital) — Series A
- Omidyar Network (https://capitalatlas.ai/funds/omidyar-network) — Series A
- S2G Ventures (https://capitalatlas.ai/funds/s2g-ventures) — Series A
- UL Ventures (https://capitalatlas.ai/funds/ul-ventures) — Series A
- Bunge Limited — Series A
- Spero Ventures (https://capitalatlas.ai/funds/spero-ventures) — Series A